PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb
Evolving strategic relationship will drive the use of artificial intelligence (AI)-powered pathology in translational research and clinical trials. BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. The initial work within this extended agreement will focus on key translational research in oncology, fibrosis, and immunology, … [Read more…]
